Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
11.9 EUR | -0.42% | -0.83% | -6.67% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 358M | |
+23.55% | 562B | |
-5.03% | 358B | |
+19.24% | 322B | |
+8.31% | 297B | |
+12.28% | 219B | |
+6.35% | 199B | |
-9.90% | 196B | |
-8.41% | 149B | |
-5.08% | 146B |
- Stock Market
- Equities
- HYL Stock
- News Hyloris Pharmaceuticals SA
- Hyloris Pharmaceuticals' : Post-Operative Pain Treatment Gets Regulatory Approvals in UK, Ireland